Update in Hepatitis C virus associated extrahepatic manifestations;Actualités des manifestations extrahépatiques associées au virus de l'hépatite C

Revue de Medecine Interne

Volumn 28, Issue 6, 2007, Pages 388-393

  Sene D ^a   Saadoun, D ^a   Limal, N ^a   Piette, J C ^a   Cacoub, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cryoglobulinemia; Extra hepatic manifestations; Hepatitis C; Lymphoma; Vasculitis

Indexed keywords

AUTOANTIBODY; CD20 ANTIBODY; CRYOGLOBULIN; PEGINTERFERON; RIBAVIRIN; RITUXIMAB;

ANTIBODY PRODUCTION; B LYMPHOCYTE; CHRONIC FATIGUE SYNDROME; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; HEMATOLOGIC MALIGNANCY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LYMPHOCYTE PROLIFERATION; LYMPHOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SHORT SURVEY; SJOEGREN SYNDROME; TH2 CELL; BLOOD; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOPROLIFERATIVE DISEASE; REVIEW;

AUTOANTIBODIES; CRYOGLOBULINEMIA; DIABETES MELLITUS, TYPE 1; FATIGUE SYNDROME, CHRONIC; HEPATITIS C; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; SJOGREN'S SYNDROME;

EID: 34248164066     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.10.321     Document Type: Short Survey

References (47)

1. Sène D., Limal N., and Cacoub P. Hepatitis C virus-associated extrahepatic manifestations: a review. Metab. Brain Dis. 19 (2004) 357-381
2. Cacoub P., Fabiani F.L., Musset L., Perrin M., Frangeul L., Leger J.M., et al. Mixed cryoglobulinemia and hepatitis C virus. Am. J. Med. 96 (1994) 124-132
3. Pawlotsky J.M., Ben Yahia M., Andre C., Voisin M.C., Intrator L., Roudot-Thoraval F., et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 19 (1994) 841-848
4. Donada C., Crucitti A., Donadon V., Tommasi L., Zanette G., Crovatto M., et al. Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia. J. Viral Hepat. 5 (1998) 179-185
5. Cacoub P., Poynard T., Ghillani P., Charlotte F., Olivi M., Piette J.C., et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 42 (1999) 2204-2212
6. Cacoub P., Renou C., Rosenthal E., Cohen P., Loury I., Loustaud-Ratti V., et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'étude et de recherche en medecine interne et maladies infectieuses sur le virus de l'Hépatite C. Medicine (Baltimore) 79 (2000) 47-56
7. Cicardi M., Cesana B., Del Ninno E., Pappalardo E., Silini E., Agostoni A., et al. Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J. Viral Hepat. 7 (2000) 138-143
8. Nagasaka A., Takahashi T., Sasaki T., Takimoto K., Miyashita K., Nakamura M., et al. Cryoglobulinemia in Japanese patients with chronic hepatitis C virus infection: host genetic and virological study. J. Med. Virol. 65 (2001) 52-57
9. Sène D., Ghillani-Dalbin P., Thibault V., Guis L., Musset L., Duhaut P., et al. Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus. J. Rheumatol. 31 (2004) 2199-2206
10. Cacoub P., Saadoun D., Limal N., Sene D., Lidove O., and Piette J.C. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 52 (2005) 911-915
11. Zaja F., Russo D., Fuga G., Patriarca F., Ermacora A., and Baccarani M. Rituximab for the treatment of type II mixed cryoglobulinemia. Haematologica 84 (1999) 1157-1158
12. Lamprecht P., Lerin-Lozano C., Merz H., Dennin R.H., Gause A., Voswinkel J., et al. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann. Rheum. Dis. 62 (2003) 1230-1233
13. Sansonno D., De Re V., Lauletta G., Tucci F.A., Boiocchi M., and Dammacco F. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 101 (2003) 3818-3826
14. Zaja F., De Vita S., Mazzaro C., Sacco S., Damiani D., De Marchi G., et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101 (2003) 3827-3834
15. Roccatello D., Baldovino S., Rossi D., Mansouri M., Naretto C., Gennaro M., et al. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol. Dial. Transplant. 19 (2004) 3054-3061
16. Quartuccio L., Soardo G., Romano G., Zaja F., Scott C.A., Marchi G.D., et al. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids (2006), Rheumatology, Oxford
17. Goh J., Coughlan B., Quinn J., O'Keane J.C., and Crowe J. Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur. J. Gastroenterol. Hepatol. 11 (1999) 833-838
18. Poynard T., Cacoub P., Ratziu V., Myers R.P., Dezailles M.H., Mercadier A., et al. Fatigue in patients with chronic hepatitis C. J. Viral Hepat. 9 (2002) 295-303
19. Wattiaux M.J. Syndrome de Gougerot Sjögren et virus de l'hépatite C : quels liens ?. Presse Med. 26 (1997) 652-655
20. Vitali C., Sciuto M., Neri R., Greco F., Mavridis A.K., Tsioufas A.G., et al. Anti-hepatitis C virus antibodies in primary Sjogren's syndrome: false positive results are related to hyper-gamma-globulinaemia. Clin. Exp. Rheumatol. 10 (1992) 103-104
21. Verbaan H., Carlson J., Eriksson S., Larsson A., Liedholm R., Manthorpe R., et al. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjogren's syndrome and hepatitis C in Swedish patients. J. Intern. Med. 245 (1999) 127-132
22. Szodoray P., Csepregi A., Hejjas M., Horanyi M., and Zeher M. Study of hepatitis C virus infection in 213 Hungarian patients with Sjogren's syndrome. Rheumatol. Int. 21 (2001) 6-9
23. Loustaud-Ratti V., Riche A., Liozon E., Labrousse F., Soria P., Rogez S., et al. Prevalence and characteristics of Sjogren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study. J. Rheumatol. 28 (2001) 2245-2251
24. Ramos-Casals M., and Font J. Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr. Opin. Rheumatol. 17 (2005) 447-455
25. Ramos-Casals M., Garcia-Carrasco M., Cervera R., Filella X., Trejo O., de la Red G., et al. Th1/Th2 cytokine imbalance in patients with Sjogren syndrome secondary to hepatitis C virus infection. Semin. Arthritis Rheum. 32 (2002) 56-63
26. Toussirot E., Le Huede G., Mougin C., Balblanc J.C., Bettinger D., and Wendling D. Presence of hepatitis C virus RNA in the salivary glands of patients with Sjogren's syndrome and hepatitis C virus infection. J. Rheumatol. 29 (2002) 2382-2385
27. Koike K., Moriya K., Ishibashi K., Yotsuyanagi H., Shintani Y., Fujie H., et al. Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc. Natl. Acad. Sci. USA 94 (1997) 233-236
28. Ohoka S., Tanaka Y., Amako Y., Kohara M., Ishidate K., Watanabe M., et al. Sialadenitis in patients with chronic hepatitis C is not directly related to hepatitis C virus. Hepatol. Res. 27 (2003) 23-29
29. Cacoub P., Ratziu V., Myers R.P., Ghillani P., Piette J.C., Moussalli J., et al. Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C. J. Hepatol. 36 (2002) 812-818
30. Doffoel-Hantz V., Loustaud-Ratti V., Ramos-Casals M., Alain S., Bezanahary H., Liozon E., et al. Évolution des syndromes de Gougerot-Sjögren associés au virus de l'hépatite C sous interféron et l'association interféron-ribavirine. Rev. Med. Interne 26 (2005) 88-94
31. Hermine O., Lefrere F., Bronowicki J.P., Mariette X., Jondeau K., Eclache-Saudreau V., et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N. Engl. J. Med. 347 (2002) 89-94
32. Saadoun D., Suarez F., Lefrere F., Valensi F., Mariette X., Aouba A., et al. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?. Blood 105 (2005) 74-76
33. Caronia S., Taylor K., Pagliaro L., Carr C., Palazzo U., Petrik J., et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 30 (1999) 1059-1063
34. Knobler H., Schihmanter R., Zifroni A., Fenakel G., and Schattner A. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin. Proc. 75 (2000) 355-359
35. El-Serag H.B., Hampel H., Yeh C., and Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 36 (2002) 1439-1445
36. Thuluvath P.J., and John P.R. Association between hepatitis C, diabetes mellitus, and race. a case-control study. Am. J. Gastroenterol. 98 (2003) 438-441
37. Antonelli A., Ferri C., Fallahi P., Sebastiani M., Nesti C., Barani L., et al. Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. Rheumatology (Oxford) 43 (2004) 238-240
38. Knobler H., and Schattner A. TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad. QJM 98 (2005) 1-6
39. Cacoub P., Ghillani P., Revelen R., Thibault V., Calvez V., Charlotte F., et al. Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia. J. Hepatol. 31 (1999) 598-603
40. De Rosa F.G., Pucillo L.P., Coviello R., Pirro M.R., Fiaschetti P., Candela M., et al. Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia. Hum. Immunol. 63 (2002) 751-757
41. Christodoulou D.K., Dalekos G.N., Merkouropoulos M.H., Kistis K.G., Georgitsi G., Zervou E., et al. Cryoglobulinemia due to chronic viral hepatitis infections is not a major problem in clinical practice 12 (2001) 435-441
42. Muratori P., Muratori L., Stroffolini T., Pappas G., Terlizzi P., Ferrari R., et al. Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population. Clin. Exp. Immunol. 131 (2003) 118-121
43. Cassani F., Cataleta M., Valentini P., Muratori P., Giostra F., Francesconi R., et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 26 (1997) 561-566
44. Marceau G., Lapierre P., Beland K., Soudeyns H., and Alvarez F. LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?. Hepatology 42 (2005) 675-682
45. Czaja A.J., Carpenter H.A., Santrach P.J., Moore S.B., Taswell H.F., and Homburger H.A. Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States. J. Hepatol. 18 (1993) 342-352
46. Muratori P., Muratori L., Guidi M., Granito A., Susca M., Lenzi M., et al. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin. Infect. Dis. 40 (2005) 501-507
47. Sene D., Ghillani-Dalbin P., Limal N., Thibault V., van Boekel T., Piette J.C., et al. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome. Ann. Rheum. Dis. 65 (2006) 394-397